107
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The Failure of Epigenetic Combination Therapy for Cancer and what it Might be Telling us about DNA Methylation Inhibitors

&
Pages 9-12 | Received 04 Sep 2015, Accepted 18 Sep 2015, Published online: 23 Dec 2015
 

Disclaimer

The statements and opinions made in this article are that of AS Yang and do not reflect the opinion of Spectrum Pharmaceutical Inc.

Financial & competing interests disclosure

AS Yang is a full-time employee of Spectrum Pharmaceutical Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

AS Yang is a full-time employee of Spectrum Pharmaceutical Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 130.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.